Page last updated: 2024-12-07

suphepa

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Suphepa: used for the determination of chymotrypsin in stools in diagnosis of pancreatic disease [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID102818
MeSH IDM0057604

Synonyms (21)

Synonym
suphepa
2440-62-2
4-[[1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid
4-[[(2s)-1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid
(s)-4-((2-((4-nitrophenyl)amino)-2-oxo-1-(phenylmethyl)ethyl)amino)-4-oxobutyric acid
succinyl-l-phenylalanine p-nitroanilide
butanoic acid, 4-((2-((4-nitrophenyl)amino)-2-oxo-1-(phenylmethyl)ethyl)amino)-4-oxo-, (s)-
n-succinyl-l-phenylalanine p-nitroanilide
einecs 219-472-6
AKOS015998330
FT-0634284
4-({1-benzyl-2-[(4-nitrophenyl)amino]-2-oxoethyl}amino)-4-oxobutanoic acid
1-aminoanthraquinone-5-sulfonicacidsodiumsalt
(s)-4-[[2-[(4-nitrophenyl)amino]-2-oxo-1-(phenylmethyl)ethyl]amino]-4-oxobutyric acid
mfcd03923815
suc-phe-pna
4-((1-benzyl-2-[(4-nitrophenyl)amino]-2-oxoethyl)amino)-4-oxobutanoic acid
DTXSID70947271
4-hydroxy-4-{[1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]imino}butanoic acid
LS-08289
3-({1-[(4-nitrophenyl)carbamoyl]-2-phenylethyl}carbamoyl)propanoic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (18.18)18.7374
1990's3 (27.27)18.2507
2000's1 (9.09)29.6817
2010's5 (45.45)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]